<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/780470B1-792E-4A77-A40D-587AC3A9D8B9"><gtr:id>780470B1-792E-4A77-A40D-587AC3A9D8B9</gtr:id><gtr:firstName>Cristina</gtr:firstName><gtr:surname>Rada</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DCC98BD2-14E6-4F3D-9F0E-09CA0F45942F"><gtr:id>DCC98BD2-14E6-4F3D-9F0E-09CA0F45942F</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Neuberger</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105178806"><gtr:id>60591C4C-61E7-415E-AB81-13347951DA42</gtr:id><gtr:title>DNA deamination and antibody diversification</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105178806</gtr:grantReference><gtr:abstractText>Animals and plants usually copy their DNA accurately so as to avoid mutation and remain healthy. Recent work however, has revealed an active mutation process that organisms use to gain greater immunity to disease. Enzymes, used by the immune system, have been found which alter antibody genes, causing the production of a broad range of antibodies which provide immunity to infection. A similar process is also used to fight retroviruses, such as HIV. However, whilst this active mutation mechanism is beneficial because it gives immunity, it probably also predisposes us to cancer (by creating off-target mutations) and autoimmune diseases. The aim of this work will be to increase our understanding of this active mutation process. We will also attempt to exploit this mutation process in vitro for the derivation of novel, useful proteins.</gtr:abstractText><gtr:technicalSummary>Following encounter with foreign antigen, antibodies in man and mouse are diversified by somatic hypermutation and their isotype is altered by class-switch recombination. Antibody diversification in some other species is also achieved by programmed gene conversion. These diversification strategies are all triggered by AID-catalysed dC-&amp;gt;dU deamination at the immunoglobulin locus with the precise pattern of diversification depending on the local targeting of the deamination as well as the pathway used for resolving the initiating dU:dG lesion. The major emphasis of this programme will focus on the generation and pathways of resolution of the initiating dU:dG lesion. Thus we will study the biochemical properties of AID, its mechanism of targeting to the Ig loci and the different pathways used for resolving the dU:dG lesion. We will also extend our studies on DNA deamination, investigating other related deaminases (as well as other members of the AID/APOBEC family) and investigate their roles in viral restriction, mutation and cancer. We will continue our studies exploring the possibility of recapitulating in vitro the iterative mutation/selection strategy exploited by the immune system for binding site maturation.</gtr:technicalSummary><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>11785231</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>Mutational signatures of DNA damage and repair processes</gtr:description><gtr:id>E1205076-8060-4184-B594-5E0C2167F696</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>dzR7LiAh3yw-1</gtr:outcomeId><gtr:partnerContribution>Provide reagents to LMB, lead project design and implementation</gtr:partnerContribution><gtr:piContribution>Design of the research proposal, supervision of part of project; contribute to publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>The Max Delbr?ck Center for Molecular Medicine (MDC)</gtr:department><gtr:description>Max-Delbrueck - Klaus Rajewsky</gtr:description><gtr:id>8A354717-62B7-4B57-9DB0-3E39196AF2A3</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>545cb27d53ae51.30044317-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents and contribution to project design and publications</gtr:partnerContribution><gtr:piContribution>Project design; provision of reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>COMSIG consortium</gtr:description><gtr:id>F8321CA0-9BDA-4C39-8D41-C0CE2AF9385A</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:outcomeId>5462040077d776.82066564-2</gtr:outcomeId><gtr:partnerContribution>Scientific advice</gtr:partnerContribution><gtr:piContribution>Named investigator on Wellcome trust consortium with Steve Jackson, Gurdon Istitute and Michael Stratton, Sanger Centre to investigate the origins of mutational signatures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Human mAbs to HIV</gtr:description><gtr:id>5CBCE3FC-AA3A-465C-9D1E-7B6CF74E05F3</gtr:id><gtr:impact>Publication</gtr:impact><gtr:outcomeId>PfZkVk5QtQ9-1</gtr:outcomeId><gtr:partnerContribution>Isolated and characterised other mAbs</gtr:partnerContribution><gtr:piContribution>Islolated and characterised the mAbs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>COMSIG consortium</gtr:description><gtr:id>D80E858F-1FB1-44B9-8B0E-BE2E32467599</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:outcomeId>5462040077d776.82066564-1</gtr:outcomeId><gtr:partnerContribution>Scientific advice</gtr:partnerContribution><gtr:piContribution>Named investigator on Wellcome trust consortium with Steve Jackson, Gurdon Istitute and Michael Stratton, Sanger Centre to investigate the origins of mutational signatures.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Women in Science - Sex in Science Careers Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3BADD802-7E8E-4A04-82B2-7E9DA3526113</gtr:id><gtr:impact>Was member of panel taking questions after talk; 1-to1 Q and A sessions

Raise awareness of career alternatives and build confidence among female peers</gtr:impact><gtr:outcomeId>545cb5e5bf31d1.87413202</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Memorial Symposium for Michael Neuberger</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>739B273A-7DAF-49B0-B445-8B1C9B68CC09</gtr:id><gtr:impact>Symposium was held to commemorate life and work of Dr Michael Neuberger. Therefore no measurable results were expected.

Symposium was held to commemorate life and work of Dr Michael Neuberger. Therefore no impacts were expected.</gtr:impact><gtr:outcomeId>5462058b8c8976.62516097</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LMB Open Day 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>26EBC032-2F54-4433-9F51-E88DF639C7EE</gtr:id><gtr:impact>Provided tours of lab and explained the science to members of the public. Over 2,000 people attended. Group members also help lead science activities for children.

Positive feedback and multiple requests from public for repeat event.</gtr:impact><gtr:outcomeId>fCTk5yL8vzS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit - Royal Society Summer Science Exhibition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>430AAB17-525D-4412-BEF5-792959707DC1</gtr:id><gtr:impact>Take a party of local school children to the science Open Day at the Royal Society

None measurable</gtr:impact><gtr:outcomeId>2A9D299B8D9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Columbia University Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BDC36E21-ABEB-4100-B0EB-787C207CD898</gtr:id><gtr:impact>Talk resulted in feedback which fed into subsequent publication

None yet</gtr:impact><gtr:outcomeId>545cb680d46503.12720162</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>27497</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Celltech Fellowship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>45231331-C27E-47E4-8B40-BBBCD26812B5</gtr:id><gtr:outcomeId>545b9304814a79.31445225</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>33000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lady Tata Memorial Fund, Fellowship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Lady Tata Memorial Trust</gtr:fundingOrg><gtr:id>98DA6E9B-AFD1-4964-B775-33B4C5AF5492</gtr:id><gtr:outcomeId>1C0BF5057D30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>804000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Gates Global Health Program</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>F4128679-8EAB-40A9-BFDA-F79BF188DC49</gtr:id><gtr:outcomeId>C82722036670</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BSH Travel Scholarship</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>British Society for Haematology (BSH)</gtr:fundingOrg><gtr:id>B44242A6-6A1A-46A7-A57D-071982A91CB7</gtr:id><gtr:outcomeId>cD7T5tnu1qN</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SNSF Fellowship</gtr:description><gtr:end>2008-10-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>EDE80C69-21CB-423C-86A4-8630662135A8</gtr:id><gtr:outcomeId>10BA4020FD50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8452</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Max Perutz Fund Cesar Milstein Fellowship</gtr:description><gtr:end>2006-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>89699069-EAE9-4277-B61A-B4E2FAA1D61D</gtr:id><gtr:outcomeId>6C5B9A8964D0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Darwin Trust of Edinburgh</gtr:department><gtr:description>Cesar Milstein Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>British Society for the History of Science (BSHS)</gtr:fundingOrg><gtr:id>C760119F-3D21-4159-BC7F-F259DFDA93E6</gtr:id><gtr:outcomeId>545b94870891e6.98126594</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128190</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leukaemia Research Clinical Research Training Fellowship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>03E636A5-9688-4475-814E-107B00F7148C</gtr:id><gtr:outcomeId>C594A673A890</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>131481</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Research Project</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>EBD272DD-FCB7-4463-8172-4713986396BC</gtr:id><gtr:outcomeId>phkx7pPvuY30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>127000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Ruth L Kirchstein NRSA Fellowship</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>BB9F521A-B1E0-4F67-A525-D8481174395F</gtr:id><gtr:outcomeId>n3DVJqpdDZK0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>NHMRC Biomedical Training Fellowship</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>610070F1-2F79-4E04-B919-98CA481BDDEF</gtr:id><gtr:outcomeId>8FE1E9E08F30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lady Tata Memorial Fund, Fellowship</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Lady Tata Memorial Trust</gtr:fundingOrg><gtr:id>BDABFD69-3E19-4F09-8DA9-44F1433DFB5D</gtr:id><gtr:outcomeId>QLhusbpHrEE</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NWO Postdoctoral Fellowship</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Netherlands Organisation for Scientific Research (NWO)</gtr:fundingOrg><gtr:id>E337C936-5755-4E10-8A6A-FC81A83EBDC5</gtr:id><gtr:outcomeId>0423EE048850</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>CHF</gtr:currCode><gtr:currCountryCode>Switzerland</gtr:currCountryCode><gtr:currLang>it_CH</gtr:currLang><gtr:description>SNSF Early Career Mobility</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>37E927FC-CE15-45AE-AA5C-93D8C2CCFCC1</gtr:id><gtr:outcomeId>545b906e246526.33377895</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>International Research Studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E8ED0F6B-041F-4D24-8B70-864D5F7ADCC7</gtr:id><gtr:outcomeId>B8F98E391FD0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British-Italian Partnership Programme 2008-2009</gtr:description><gtr:end>2009-11-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>E7F5A6A1-8967-433E-8EEE-868DC963466F</gtr:id><gtr:outcomeId>88D5A8486D00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Inventors have developed transgenic mice that express human immunoglobulin genes. Use of such mice to obtain human antibodies specific for particular antigens is disclosed. Patent granted</gtr:description><gtr:grantRef>MC_U105178806</gtr:grantRef><gtr:id>76F68F7B-EBB1-415A-8700-C83F481C9057</gtr:id><gtr:impact>This patent underpins several FDA-approved human mAbs taht have recently entered the clinic</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>B0EB6315A11</gtr:outcomeId><gtr:patentId>JP3871997</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Antibodies from Transgenic Mice</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Inventors describe a method for selecting hypermutating cells. Claims cover use of such cells for diversification and selection of proteins with properties of interest inside such cells. US 2008193979 (A1)</gtr:description><gtr:grantRef>MC_U105178806</gtr:grantRef><gtr:id>88098877-81E0-419E-98D6-B2850F0A51C9</gtr:id><gtr:impact>Assists in establishment of Anaptys biotechnology company</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>7CAE14314ED</gtr:outcomeId><gtr:patentId>US2008193979</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Method For Generating Diversity 2</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Method for selecting hypermutating cells and use of such cells for diversification and selection of proteins with properties of interest inside such cells.</gtr:description><gtr:grantRef>MC_U105178806</gtr:grantRef><gtr:id>AC45BA58-1AA1-4CEB-8DC7-B371BEEAEE9D</gtr:id><gtr:impact>This has been licensed to and underpins a biotechnology company, Anaptys</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>86C8A57D929</gtr:outcomeId><gtr:patentId>EP2204447</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Method For Generating Diversity</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Demonstration that AID and its family members can be used to mutate DNA in non-lymphoid organisms</gtr:description><gtr:grantRef>MC_U105178806</gtr:grantRef><gtr:id>E1ADD37A-4928-4694-9F19-895FBAF8F886</gtr:id><gtr:impact>Scientific advances</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>E00FE730253</gtr:outcomeId><gtr:patentId>US2006019262</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Activation Induced Deaminase (AID)</gtr:title><gtr:yearProtectionGranted>2006</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A variety of mouse lines carrying targeted genetic modifications</gtr:description><gtr:id>324F8EA6-4E26-4465-9A58-109B122A921C</gtr:id><gtr:impact>Assisted towards the development of novel therapeutic human antibodies or of animal models in which they can be evaluated</gtr:impact><gtr:outcomeId>62C5390EE26</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Gene modified mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Open Monoclonal technology</gtr:companyName><gtr:description>http://www.omtinc.net/
OMT is a private biotechnology company with a new, fully human monoclonal antibody (mAb) platform based on transgenic rats.</gtr:description><gtr:id>24E3A580-947E-4C37-8109-413AD32E8E18</gtr:id><gtr:impact>Successful production of human mAbs from rats</gtr:impact><gtr:outcomeId>breHxztV99g</gtr:outcomeId><gtr:url>http://www.omtinc.net/%20OMT</gtr:url><gtr:yearCompanyFormed>2008</gtr:yearCompanyFormed></gtr:spinOutOutput><gtr:spinOutOutput><gtr:companyName>AnaptysBio</gtr:companyName><gtr:description>AnaptysBio, Inc is a privately-held therapeutic antibody product company, based in San Diego, California, and the leader in the use of somatic hypermutation (SHM), for antibody discovery and optimization.&amp;nbsp; ; http://www.anaptysbio.com</gtr:description><gtr:id>06D418D0-EF35-4375-8EBB-D2999416CFC4</gtr:id><gtr:impact>In 2007 research discoveries from Dr Michael Neuberger's laboratory at MRC LMB in the field of SHM were licensed by the MRC to Anaptys Bio (in addition to research carried out at the Albert Einstein College of Medicine, AECOM). This technology has contributed significantly to the growth of the company.</gtr:impact><gtr:outcomeId>ABE62356A28</gtr:outcomeId><gtr:url>http://www.anaptysbio.com/</gtr:url><gtr:yearCompanyFormed>2005</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>E20B452B-2D8F-405E-AC93-986B3E5222BF</gtr:id><gtr:title>CTNNBL1 is a novel nuclear localization sequence-binding protein that recognizes RNA-splicing factors CDC5L and Prp31.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38fd35398a4ccb9808bae821fd0c5d44"><gtr:id>38fd35398a4ccb9808bae821fd0c5d44</gtr:id><gtr:otherNames>Ganesh K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>JApWbQ7QCxF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A9C46FC-E38C-4BAE-A594-74C9ECE4D287</gtr:id><gtr:title>CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff8d5f723bc4e0ec8c6bd174ee0fdd44"><gtr:id>ff8d5f723bc4e0ec8c6bd174ee0fdd44</gtr:id><gtr:otherNames>van Maldegem F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56d88314d746c2.36746703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A26F111E-B9F7-436A-B3D5-41E5C5BF9F67</gtr:id><gtr:title>High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Ig?/Ig? loci bearing the rat CH region.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce63901076055609b5b449e09bf2fd84"><gtr:id>ce63901076055609b5b449e09bf2fd84</gtr:id><gtr:otherNames>Osborn MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14640_20_23303672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>649BD392-593E-4379-A40F-9B544C12FBFD</gtr:id><gtr:title>ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47edb5d16b85bc6ba250caea412c82cd"><gtr:id>47edb5d16b85bc6ba250caea412c82cd</gtr:id><gtr:otherNames>Loizou JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>m1WQH6DWXBg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>561E1490-7D0C-4EE1-9291-0620843F6DA9</gtr:id><gtr:title>The relationship between hypothesis and experiment in unveiling the mechanisms of antibody gene diversification.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38fd35398a4ccb9808bae821fd0c5d44"><gtr:id>38fd35398a4ccb9808bae821fd0c5d44</gtr:id><gtr:otherNames>Ganesh K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>HWkwiCpaRDg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41A706A6-0137-48FF-A825-3D8E5EFF9653</gtr:id><gtr:title>Deficiency in spliceosome-associated factor CTNNBL1 does not affect ongoing cell cycling but delays exit from quiescence and results in embryonic lethality in mice.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bac50221dc503170820594fbe6ef3a1b"><gtr:id>bac50221dc503170820594fbe6ef3a1b</gtr:id><gtr:otherNames>Chandra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_14640_20_23343763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87E84858-8CCA-477C-B902-FE6F74CF0282</gtr:id><gtr:title>The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e37f701aa5b7d668525fbeb3de35556b"><gtr:id>e37f701aa5b7d668525fbeb3de35556b</gtr:id><gtr:otherNames>Langlois MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>ED938130C6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C776AE19-B505-45D1-A9B8-61F7ABA6418E</gtr:id><gtr:title>The dependence of Ig class-switching on the nuclear export sequence of AID likely reflects interaction with factors additional to Crm1 exportin.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c6d01f43e6079b9ba53670dc7415ce6"><gtr:id>5c6d01f43e6079b9ba53670dc7415ce6</gtr:id><gtr:otherNames>Ellyard JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>hZXi1sE81ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E275413-B895-4675-A839-A2FE090D446B</gtr:id><gtr:title>Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1a (eEF1A).</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb2eac59ce30a0295082d3a2a2ed6098"><gtr:id>cb2eac59ce30a0295082d3a2a2ed6098</gtr:id><gtr:otherNames>H?sler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>tM3m1SVWsMv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D70BBC7E-3F11-486B-9FC0-575E1DDF335F</gtr:id><gtr:title>Mutational processes molding the genomes of 21 breast cancers.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eca6d7fe74368290f4af60070bc34872"><gtr:id>eca6d7fe74368290f4af60070bc34872</gtr:id><gtr:otherNames>Nik-Zainal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_14640_20_22608084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D487ABF3-9D2D-480F-82ED-C53647B46A01</gtr:id><gtr:title>AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737ffe0e530a693d7c0da01892f1528d"><gtr:id>737ffe0e530a693d7c0da01892f1528d</gtr:id><gtr:otherNames>Wang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>030882F0A89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5774D0BA-7AFB-44C6-AFCE-5EEFBF08A348</gtr:id><gtr:title>Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo-relative, karyopherin a.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38fd35398a4ccb9808bae821fd0c5d44"><gtr:id>38fd35398a4ccb9808bae821fd0c5d44</gtr:id><gtr:otherNames>Ganesh K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>544a1e1bced261.08697229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D8ED0CD-BC53-4578-B389-61A66C1A4377</gtr:id><gtr:title>SMUG1 is able to excise uracil from immunoglobulin genes: insight into mutation versus repair.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7152ce561ddc2f144dd281c06da6bdd"><gtr:id>d7152ce561ddc2f144dd281c06da6bdd</gtr:id><gtr:otherNames>Di Noia JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>A3D122F9F43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2874F6B-2A41-4EA4-A5C6-730B86944EE7</gtr:id><gtr:title>Pillars article: AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002. 418: 99-103.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c7f03db1974a276631cb46d0671a2a"><gtr:id>e1c7f03db1974a276631cb46d0671a2a</gtr:id><gtr:otherNames>Petersen-Mahrt SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58a499af0e2055.99666457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A8F4F6D-2F10-401E-B32F-4A2F0AC83B53</gtr:id><gtr:title>Apobec2 deficiency causes mitochondrial defects and mitophagy in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1611b877eb281ec7d623fc4cb55653c"><gtr:id>c1611b877eb281ec7d623fc4cb55653c</gtr:id><gtr:otherNames>Sato Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5a9d79bbb207b9.51384052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9357F652-FAAA-4912-8BEB-212B9E0935D5</gtr:id><gtr:title>Uracil excision by endogenous SMUG1 glycosylase promotes efficient Ig class switching and impacts on A:T substitutions during somatic mutation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09a7bc49223da82d19573d23ad35df0"><gtr:id>b09a7bc49223da82d19573d23ad35df0</gtr:id><gtr:otherNames>Dingler FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>545b8c91ddef93.80708296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3598DD8-1F20-4FDC-BFC1-2631DBA6F585</gtr:id><gtr:title>Uracil Accumulation and Mutagenesis Dominated by Cytosine Deamination in CpG Dinucleotides in Mice Lacking UNG and SMUG1.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca6e9d0bad08b70713dc626c1d77b16c"><gtr:id>ca6e9d0bad08b70713dc626c1d77b16c</gtr:id><gtr:otherNames>Als?e L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9d7995ddc552.95283905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE0F2267-579C-405B-A344-5AEE7DDAFEE0</gtr:id><gtr:title>Active demethylation in mouse zygotes involves cytosine deamination and base excision repair.</gtr:title><gtr:parentPublicationTitle>Epigenetics &amp; chromatin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a2baed34e507aed3a886e243596924d"><gtr:id>3a2baed34e507aed3a886e243596924d</gtr:id><gtr:otherNames>Santos F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1756-8935</gtr:issn><gtr:outcomeId>545b8c91b5a421.70115601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D7CF216-BC60-4111-A049-4B44234AC30B</gtr:id><gtr:title>microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>C6BE4383B6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFE3EBB5-37EA-47E3-9113-E2BADC114D23</gtr:id><gtr:title>DNA deamination in immunity: AID in the context of its APOBEC relatives.</gtr:title><gtr:parentPublicationTitle>Advances in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e78f2eaabec13daf7e953ba381ba796"><gtr:id>1e78f2eaabec13daf7e953ba381ba796</gtr:id><gtr:otherNames>Conticello SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0065-2776</gtr:issn><gtr:outcomeId>FF456E9A94B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82DA789F-7EF3-42AE-9700-70E6C3D28EC9</gtr:id><gtr:title>The cytoplasmic AID complex.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb2eac59ce30a0295082d3a2a2ed6098"><gtr:id>cb2eac59ce30a0295082d3a2a2ed6098</gtr:id><gtr:otherNames>H?sler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>pm_14640_20_22698843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>074D6487-5FFE-4DFA-9D5E-ACB9DEF802CD</gtr:id><gtr:title>REG-? associates with and modulates the abundance of nuclear activation-induced deaminase.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e4cf442f17c4cd3d27c85c4e0cea8f4"><gtr:id>0e4cf442f17c4cd3d27c85c4e0cea8f4</gtr:id><gtr:otherNames>Uchimura Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>mUb3SQkDNz9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CEB41A0-3C19-4E4A-828F-F3F9E35A03B7</gtr:id><gtr:title>The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0239ee8ea320130081bf80d8d51bae8c"><gtr:id>0239ee8ea320130081bf80d8d51bae8c</gtr:id><gtr:otherNames>Xue K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>73CABF5A651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B4C012-EFB2-4A1F-BFA4-3856EAEA2F56</gtr:id><gtr:title>Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e37f701aa5b7d668525fbeb3de35556b"><gtr:id>e37f701aa5b7d668525fbeb3de35556b</gtr:id><gtr:otherNames>Langlois MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>995B18CA1D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04FA2FED-511E-4FE6-BE8A-D3260484C469</gtr:id><gtr:title>Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08113321f24b6b6673314e0202f493a5"><gtr:id>08113321f24b6b6673314e0202f493a5</gtr:id><gtr:otherNames>Pruzina S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>QFYEMpmuWNk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B65B1F27-6F74-4D02-AC3E-062FFF809C2E</gtr:id><gtr:title>MDM2 can interact with the C-terminus of AID but it is inessential for antibody diversification in DT40 B cells.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e4c6d810c82f66b60a9a2b5c7e2131"><gtr:id>38e4c6d810c82f66b60a9a2b5c7e2131</gtr:id><gtr:otherNames>MacDuff DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>F943E6E7BBB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>861A37DA-AD9F-4E30-BF18-5ECD47821FBA</gtr:id><gtr:title>Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e78f2eaabec13daf7e953ba381ba796"><gtr:id>1e78f2eaabec13daf7e953ba381ba796</gtr:id><gtr:otherNames>Conticello SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>916261543F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>454EA3B0-D8A0-4C67-8998-A6305C02F1C2</gtr:id><gtr:title>DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c20fbf058d1b320731f91f2c60e5a05"><gtr:id>3c20fbf058d1b320731f91f2c60e5a05</gtr:id><gtr:otherNames>Taylor BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>pm_14640_20_23599896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD0DCEAC-FE41-454B-B8D1-83F00741B67F</gtr:id><gtr:title>Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c388a7bb040de3b4d4ac1f09887946d"><gtr:id>9c388a7bb040de3b4d4ac1f09887946d</gtr:id><gtr:otherNames>Neuberger MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>FE7E8A1D2FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFCDE187-A6D9-4C92-90FD-936D1F3C4210</gtr:id><gtr:title>Molecular mechanisms of antibody somatic hypermutation.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7152ce561ddc2f144dd281c06da6bdd"><gtr:id>d7152ce561ddc2f144dd281c06da6bdd</gtr:id><gtr:otherNames>Di Noia JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>9AA1C1CC7E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49CBB408-DCA0-487E-BF13-629332E5FD3C</gtr:id><gtr:title>A high-throughput assay for DNA deaminases.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737ffe0e530a693d7c0da01892f1528d"><gtr:id>737ffe0e530a693d7c0da01892f1528d</gtr:id><gtr:otherNames>Wang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>sGJQiTVjKi6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52E57160-667F-4753-86D6-0F8A08AEDB64</gtr:id><gtr:title>Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60aece3a031434188a008d207b23f5a4"><gtr:id>60aece3a031434188a008d207b23f5a4</gtr:id><gtr:otherNames>Takeda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>AF6AD983D7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76D9F3A8-B6C7-41BF-8546-2F7199DB89D2</gtr:id><gtr:title>Directed evolution of human scFvs in DT40 cells.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f61651130ee7c62d38b8dee3a8f60db2"><gtr:id>f61651130ee7c62d38b8dee3a8f60db2</gtr:id><gtr:otherNames>Lim AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>58a49e9dbf03d7.19103920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>063D2551-528D-470A-B4D1-854EAF9B7614</gtr:id><gtr:title>Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c20fbf058d1b320731f91f2c60e5a05"><gtr:id>3c20fbf058d1b320731f91f2c60e5a05</gtr:id><gtr:otherNames>Taylor BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>545b8c918e5756.82954677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1B273A5-F250-4179-AAC4-66D02A6834CC</gtr:id><gtr:title>Antibody diversification by somatic mutation: from Burnet onwards.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c388a7bb040de3b4d4ac1f09887946d"><gtr:id>9c388a7bb040de3b4d4ac1f09887946d</gtr:id><gtr:otherNames>Neuberger MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>246AA7F2967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF063769-4C12-4D20-8985-E2C355CBC049</gtr:id><gtr:title>Dependence of antibody gene diversification on uracil excision.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7152ce561ddc2f144dd281c06da6bdd"><gtr:id>d7152ce561ddc2f144dd281c06da6bdd</gtr:id><gtr:otherNames>Di Noia JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>6B22D7893A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4349F48-22E1-46FD-851C-2F937FE28418</gtr:id><gtr:title>Mutagenesis by AID: Being in the Right Place at the Right Time.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8554a47c8b89550f15d9d6a9e5ea2ef"><gtr:id>b8554a47c8b89550f15d9d6a9e5ea2ef</gtr:id><gtr:otherNames>Rada C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56d882953d5fc4.78979935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02752AF3-EB4B-48FD-B087-0D86270BCC01</gtr:id><gtr:title>Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737ffe0e530a693d7c0da01892f1528d"><gtr:id>737ffe0e530a693d7c0da01892f1528d</gtr:id><gtr:otherNames>Wang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pGhCb2xYtaD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55E985F7-CD73-48BF-817E-46790160DED4</gtr:id><gtr:title>Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f6af75670a188a94192414c08d12f5"><gtr:id>44f6af75670a188a94192414c08d12f5</gtr:id><gtr:otherNames>Sheppard NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>1A50ED5A6E3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF3C9EBB-44FD-4F16-871B-E8612354E54B</gtr:id><gtr:title>The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/986e6a21910915049c362fd3891d117d"><gtr:id>986e6a21910915049c362fd3891d117d</gtr:id><gtr:otherNames>Geisberger R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>DA642CA1143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB532B12-915D-498E-995B-864D60293358</gtr:id><gtr:title>Molecular fine-tuning of affinity maturation in germinal centers.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39bb6d92ef9da2390ac6bafe8e8bdfcf"><gtr:id>39bb6d92ef9da2390ac6bafe8e8bdfcf</gtr:id><gtr:otherNames>Wu YL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>585d6b53041d43.13211392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C7D1C7B-0F02-4E73-85E3-E3C5D3614F3C</gtr:id><gtr:title>Germline ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil- and UNG-backup uracil-excision activities and increases cancer predisposition of Ung-/-Msh2-/- mice.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95e00415e37a1ed87f4ce21fa692354b"><gtr:id>95e00415e37a1ed87f4ce21fa692354b</gtr:id><gtr:otherNames>Kemmerich K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_14640_20_22447450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B9A0295-7D49-48DB-B3B1-EF5BAF2EAD8D</gtr:id><gtr:title>Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1611b877eb281ec7d623fc4cb55653c"><gtr:id>c1611b877eb281ec7d623fc4cb55653c</gtr:id><gtr:otherNames>Sato Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>YEA2mE73Huh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EC6E2F3-D1FD-4DB6-B182-C5E6EC2F5D3D</gtr:id><gtr:title>Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fen1 mice mutants.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0af31efd20b032116bdd60b6e377182c"><gtr:id>0af31efd20b032116bdd60b6e377182c</gtr:id><gtr:otherNames>Larsen E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>1A868B7F734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA5A5F17-3CC1-482D-8A80-4CA9F94E358B</gtr:id><gtr:title>Wartime discoveries on amino acids: functions in protein structure and as a dietary nitrogen source</gtr:title><gtr:parentPublicationTitle>Biochemical Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64c42364226686a4ef187e54e37f089b"><gtr:id>64c42364226686a4ef187e54e37f089b</gtr:id><gtr:otherNames>Neuberger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_14640_20_22967126</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105178806</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>